Identification and validation of monocyte to macrophage differentiation-associated as a prognostic biomarker in gastric cancer [0.03%]
胃癌中单核细胞向巨噬细胞分化相关基因作为预后生物标志物的鉴定与验证
Suyang Bai,Zhaofeng Chen,Rui Ji et al.
Suyang Bai et al.
Background: Gastric cancer (GC) has a very poor prognosis as most cases are diagnosed at a late stage, which can be partially attributed to a lack of reliable diagnostic biomarkers. Our study reveals a close correlation b...
Case Report: Giant cell lesions in the Maxillofacial region: diagnostic points and treatment strategies [0.03%]
病例报告：颌面部巨大细胞病变的诊断要点和治疗策略
Xiaohan Gao,Shuangyi Wang,Xiaohong Zhan et al.
Xiaohan Gao et al.
Objective: Giant cell-rich lesions in the maxillofacial region are relatively rare, and comprehensive clinical differential diagnostic protocols are currently lacking. This article aims to provide a reference for the clin...
Advanced lung adenocarcinoma harboring uncommon EGFR 19 Del and T790M/trans-C797S mutations after resistance: a case report and literature review [0.03%]
罕见EGFR 19号外显子缺失和T790M/反式C797S突变的晚期肺腺癌患者在耐药后病例报道及文献回顾
Yuting Xiao,Dunqiang Ren,Huanhuan Bi et al.
Yuting Xiao et al.
The most common epidermal growth factor receptor (EGFR) mutation in non-small cell lung cancer (NSCLC) is exon 19 deletion (19del), which is sensitive to EGFR tyrosine kinase inhibitors (EGFR-TKIs). However, uncommon EGFR 19del mutations ex...
The resection of extraosseous osteosarcoma was accompanied by the occurrence of pulmonary metastasis and distal metastasis at the primary site: a case report [0.03%]
骨外尤文肉瘤的外科切除伴发肺及原发灶远处转移：1例报告
Han Liu,Leilei Tian,Jianhua Mu et al.
Han Liu et al.
Background: Extraskeletal osteosarcoma (ESOS) is a rare and aggressive malignancy, comprising approximately 1% of all soft tissue sarcomas and 4.3% of all osteosarcomas. It predominantly affects individuals between the ag...
Establishing an intraoperative, mobile CBCT-based workflow for gynecologic brachytherapy: primary experience and benefit assessment [0.03%]
基于术中移动CBCT的妇科近距离放射治疗工作流程建立及初步临床应用评估
Andre Karius,Vratislav Strnad,Christoph Bert et al.
Andre Karius et al.
Background and purpose: In the brachytherapy of cervical cancer, creating a suitable implant based on ultrasound guidance may be impacted by imaging limitations. To validate the implant if ultrasound is not sufficient, we...
Case Report: A case of first-line treatment for rare ROS1 fusion mutation lung adenocarcinoma with entrectinib [0.03%]
恩曲替尼治疗罕见ROS1融合突变肺腺癌病例报告
Yifan Yang,Qing Yi,Wei Yang et al.
Yifan Yang et al.
The incidence of the ROS1 fusion mutation (ROS proto-oncogene 1) in non-small cell lung cancer (NSCLC) is approximately 1-2%. At least 55 partner genes have been identified that can fuse with ROS1.Herein, we report a case of a lung adenocar...
Case Report: A rare case of sintilimab-induced dermatomyositis in a patient with gastric cancer [0.03%]
西妥珠单抗诱导的皮肌炎一例报告
Peipei Mou,Fanghua Li,Yingying Wang et al.
Peipei Mou et al.
The PD-1 inhibitor sintilimab has been approved for the treatment of various malignancies. Here, we reported a rare case of sintilimab-induced dermatomyositis in a patient with gastric cancer and liver metastasis to raise awareness of this ...
Efficacy and safety of immune checkpoint inhibitors for brain metastases of non-small cell lung cancer: a systematic review and network meta-analysis [0.03%]
免疫检查点抑制剂治疗非小细胞肺癌脑转移的疗效和安全性：系统评价和网络meta分析
Bin Liu,Jie Chen,Mingqi Luo
Bin Liu
Background: Previous studies have demonstrated that immune checkpoint inhibitors (ICIs) significantly improve prognosis in lung cancer patients with brain metastases (BMs). This systematic review and network meta-analysis...
The therapeutic effect of acupuncture in the treatment of chemotherapy-induced peripheral neuropathy: a randomized controlled trial [0.03%]
针刺治疗化疗诱导的外周神经病变疗效观察：随机对照试验研究报告
Jinqun Xu,Qing Zhang,Na Xue et al.
Jinqun Xu et al.
Introduction: Effective treatments for preventing and treating chemotherapy-induced peripheral neuropathy (CIPN) are still under exploration. Acupuncture in the treatment of CIPN requires more clinical trial data. This st...
Additional prognostic value of the BCT score in ER+HER2- breast cancer patients receiving a 21-gene assay-guided adjuvant treatments [0.03%]
BCT评分为雌激素受体阳性且人表皮生长因子受体阴性的乳腺癌患者在接受21基因检测指导下的辅助治疗提供预后价值
Sung Gwe Ahn,Jonghan Yu,Seung Ho Baek et al.
Sung Gwe Ahn et al.
Background: The 21-gene recurrence score (RS)-guided decision-making for adjuvant treatment has been utilized as a standard of care for early ER+HER2- breast cancer. We investigated a prognostic value of the Breast Cancer...